Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

New insights in the treatment of idiopathic pulmonary fibrosis

Oral Presentation
Chairs: G. Raghu (Seattle, United States of America), R. M. du Bois (London, United Kingdom)

Download all media

Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial U. Costabel, L. Richeldi, M. Selman, D. S. Kim, K. K. Brown, K. R. Flaherty, P. W. Noble, G. Raghu, M. Brun, A. Gupta, M. Klueglich, N. Juhel, R. M. du Bois (Essen, Biberach, Germany; Modena, Italy; México, Mexico; Seoul, Republic Of Korea; Denver, Ann Arbor, Durham, Seattle, United States Of America; Reims, France; London, United Kingdom)
Effect of baseline FVC on preservation of lung function with BIBF 1120: Results from the TOMORROW trial L. Richeldi, U. Costabel, M. Selman, D. S. Kim, K. R. Flaherty, P. W. Noble, G. Raghu, A. Azuma, M. Brun, A. Gupta, M. Klueglich, N. Juhel, R. M. du Bois (Modena, Italy; Essen, Biberach, Germany; Mèxico, Mexico; Seoul, Republic Of Korea; Ann Arbor, Durham, Seattle, United States Of America; Tokyo, Japan; Reims, France; London, United Kingdom)
The long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Interim data from the RECAP extension study U. Costabel, C. Albera, A. Cohen, W. Bradford, T. King, Jr., P. Noble, S. Sahn, D. Valeyre, R. du Bois (Essen, Germany; Torino, Italy; Brisbane, San Francisco, Durham, Charleston, United States Of America; Paris, France; London, United Kingdom)
Antifibrosic effects of sulforaphane in human lung fibroblasts from idiopathic pulmonary fibrosis E. Artaud-Macari, D. Goven, S. Brayer, J. Marchal-Somme, B. Crestani, A. Boutten, M. Bonay (Paris, France)
Presence of right ventricular dysfunction predicts dyspnea and quality of life improvements with sildenafil in IPF M. Han, D. Bach, P. Hagan, S. Schmidt, K. Flaherty, G. Toews, R. Edwards, E. Yow, K. Anstrom, F. Martinez (Ann Arbor, Durham, United States Of America)
A prospective, non randomized, clinical trial to study the safety and efficacy of the endobronchial autologous infusion of adipose-derived mesenchymal stem cells (ADMSCs) in patients with idiopathic pulmonary fibrosis (IPF) A. Tzouvelekis, P. Ntolios, A. Ekonomou, G. Koliakos, M. Froudarakis, D. Bouros (AL, Alexandroupolis, Thessaloniki, Greece)
Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study A. Tzouvelekis, E. Bouros, A. Ekonomou, P. Ntolios, G. Zacharis, G. Kolios, D. Bouros (Alexandroupolis, Greece)